AORT Artivion Inc: Utang-utang marang kapitalisasi buku

Logo korporat perusahaan CryoLife (AORT)

The price visualization for Artivion, Inc. (AORT) on GURU.Markets illustrates the asset's dynamics, where the current indicator stands at 0.86. Artivion, Inc. specializes in the development of heart valves and aortic surgery systems, leveraging the success of On-X and the approval of new stent grafts. The company's environmental focus centers on bioethics and energy efficiency during implant production. Its strategic course is aimed at the global promotion of tissue processing methods and the maintenance of high profitability.

Artivion Corp - Utang-utang marang aset resik AORT (periode 04.07.2022 - 30.10.2026)
Produk asli CryoLife

Artivion, Inc. (AORT) investments in the robotization of bioprosthesis production require significant capital, meaning the debt-to-book capitalization ratio trend allows for an assessment of the efficiency of borrowed funds utilization. This indicator measures the degree of financial leverage by comparing total accounts payable to equity, helping investors determine the balance between default risk and the potential for increased return on assets.

Pesaing langsung

Utang-utang marang kapitalisasi buku BSX (Boston Scientific)|edwards.com (EW) - Utang-utang marang nilai buku|ResMed - Utang-utang marang kapitalisasi buku|Insulet Corp (PODD) - Utang marang nilai buku|ZBH: Utang-utang marang kapitalisasi buku|COO - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku globusmedical.com|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku ATEC (Alphatec Holdings)|Utang-utang marang kapitalisasi buku ENOV (DJO Global)|Utang-utang marang aset resik Integra LifeSciences Inc. (IART)|ESTA: Utang marang nilai buku|Rasio utang-utang marang kapitalisasi buku BBNX|IRMD: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Embecta Corp (EMBC)|TNDM (Tandem Diabetes) - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku AXGN (Axogen Surgical)|Utang marang nilai buku SIBN (SI-BONE, Inc.)|OFIX (orthofix.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Bioventus BVS|KIDS - Utang marang nilai buku|Treace Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Strata Medical|CARL: Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku RXST|CLPT (ClearPoint Neuro Inc.) - Utang-utang marang kapitalisasi buku|Stereotaxis Inc (STXS) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku STIM|Utang marang nilai buku Sight Sciences Inc SGHT|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Utang-utang marang kapitalisasi buku Anika Therapeutics Inc. ANIK|NSPR - Rasio utang marang kapitalisasi buku|ZJYL: Rasio utang marang kapitalisasi buku|VANI (vivani.com) - Utang marang nilai buku|Xtant Medical - Rasio utang marang aset resik|NMTC (NeuroOne Medical Technologies) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Modular Med MODD|Rasio utang marang kapitalisasi buku Myomo (MYO)|Envoy Medical Inc. (COCH) - Utang marang aset resik|Vivos Therapeutics, Inc - Utang marang nilai buku|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|SINTX Technologies - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik tenonmed.com TNON|Lifeward (LFWD) - Rasio utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku AMIX (Autonomix Medical)|Rasio utang marang kapitalisasi buku INVO Bioscience, Inc.|Utang marang nilai buku Bone Biologics Inc (BBLG)|Utang-utang marang kapitalisasi buku AXNX|BIOL - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Dynatronics DYNT|FNA: Rasio utang marang nilai buku|INVO: Utang marang nilai buku